View Older Stories View More Recent Stories

Mar 21, 2016 07:00AM Horizon Pharma plc Receives Health Canada Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Treatment of Urea Cycle Disorders in Patients Two Years of Age and Older
Mar 16, 2016 07:05AM Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for RAVICTI-Related Patent App
Mar 16, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid
Mar 14, 2016 07:19AM Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for VIMOVO-Related Patent
Mar 14, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Mar 8, 2016 07:16PM INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against Horizon Pharma plc and Strongly Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
Mar 2, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) (diclofenac sodium topical solution) 2% w/w
Mar 1, 2016 07:00AM Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 07:30AM Horizon Pharma plc Recognizes Rare Disease Community on the "Rarest Day of the Year"
Feb 29, 2016 07:00AM Horizon Pharma plc Announces Record Fourth-Quarter and Full-Year 2015 Financial Results and Confirms Full-Year 2016 Sales and Adjusted EBITDA Guidance
Feb 22, 2016 07:00AM Horizon Pharma plc Announces That Health Canada Determines RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid Is Eligible for Data Protection
Jan 29, 2016 07:00AM Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016
Jan 28, 2016 07:00AM Horizon Pharma plc to Participate in Three Investor Conferences in February
Jan 14, 2016 07:05AM National Health Partners (HPR) Completes $510M Acquisition of Crealta Holdings
Jan 14, 2016 07:00AM Horizon Pharma plc Completes Acquisition of Crealta Holdings LLC
Jan 12, 2016 07:00AM Horizon Pharma plc Raises Full-Year 2016 Net Sales and Adjusted EBITDA Guidance Based on Expected Close of the Crealta Holdings LLC Acquisition
Jan 6, 2016 07:00AM Horizon Pharma plc to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 4, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid
Dec 17, 2015 07:00AM Horizon Pharma plc to Present at the 34th Annual J.P. Morgan Healthcare Conference
Dec 14, 2015 07:02AM National Health Partners (HPR) Enters ACTIMMUNE Phase 1 with Fox Chase Cancer Center
Dec 14, 2015 07:00AM Horizon Pharma plc and Fox Chase Cancer Center Temple Health Initiate Phase 1 Study to Evaluate ACTIMMUNE(R) (interferon gamma-1b) in Combination With Nivolumab in Patients With Advanced Solid Tumors
Dec 11, 2015 07:01AM Horizon Pharma (HZNP) to Acquire Crealta Holdings in $510M Cash Deal
Dec 11, 2015 07:00AM Horizon Pharma plc to Acquire Crealta Holdings LLC in All Cash Acquisition
Dec 1, 2015 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) 2%
Nov 30, 2015 07:00AM Horizon Pharma plc Receives European Commission Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Treatment of Urea Cycle Disorders in Patients Two Months of Age and Older
Nov 19, 2015 07:56PM Horizon Pharma plc Withdraws Offer to Acquire Depomed, Inc.
Nov 19, 2015 07:00AM Horizon Pharma plc to Present at Two Conferences in December
Nov 13, 2015 02:00PM Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc.
Nov 13, 2015 07:30AM Horizon Pharma plc Selected as One of Chicago Tribune's Top Workplaces in 2015
Nov 13, 2015 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Nov 11, 2015 04:04PM SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Horizon Pharma plc and Encourages Investors to Contact the Firm
Nov 11, 2015 07:15AM Horizon Pharma plc Provides Comment on Express Scripts' Business Practices
Nov 11, 2015 07:00AM Horizon Pharma plc Announces Collaboration With Alliance for Lupus Research to Study RAYOS(R) (prednisone) Delayed-Release Tablets in Systemic Lupus Erythematosus
Nov 10, 2015 10:22PM Horizon Pharma plc Responds to Express Scripts Lawsuit and Recent Allegations
Nov 9, 2015 07:00AM Horizon Pharma plc Announces 2016 Net Sales and Adjusted EBITDA Guidance; Reviews 2020 Long-Range Plan
Nov 6, 2015 07:00AM Horizon Pharma plc Announces Exceptional Third-Quarter 2015 Financial Results and Significantly Raises Full-Year 2015 Sales and Adjusted EBITDA Guidance
Nov 5, 2015 07:00AM Horizon Pharma plc Announces Clinical Data to Be Presented at the 2015 ACR/ARHP Annual Meeting
Nov 4, 2015 07:00AM Horizon Pharma plc to Present at Three Conferences in November
Nov 2, 2015 04:01PM Horizon Pharma plc to Host Investor Day on November 9, 2015
Oct 27, 2015 04:05PM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Oct 26, 2015 05:41PM Horizon Pharma plc Extends Offer to Acquire Depomed, Inc.
Oct 22, 2015 05:38PM Horizon Pharma plc Corrects Misinformation in the Marketplace
Oct 22, 2015 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) (diclofenac sodium topical solution) 2%
Oct 21, 2015 05:55PM Horizon Pharma plc Provides Update on Relationship With Specialty Pharmacies
Oct 21, 2015 03:40PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Claims Against Horizon Pharma plc And Encourages Investors To Contact The Firm
Oct 21, 2015 07:00AM Horizon Pharma plc Announces Favorable Markman Ruling in RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid Patent Infringement Lawsuit
Oct 16, 2015 07:00AM Horizon Pharma plc to Host Third Quarter 2015 Conference Call and Webcast on November 6, 2015
Oct 15, 2015 07:00AM Horizon Pharma plc Files Definitive Proxy Statement for Extraordinary General Meeting of Horizon Pharma Shareholders
Oct 13, 2015 04:30PM Horizon Pharma plc Files Preliminary Proxy Materials for Special Meetings
Oct 9, 2015 07:00AM Horizon Pharma plc Chairman and Chief Executive Officer Timothy P. Walbert Inducted Into Chicago Area Entrepreneurship Hall of Fame at UIC Institute for Entrepreneurial Studies
View More Recent Stories View Older Stories